Skip to main content
. 2017 Nov 16;7(11):e014549. doi: 10.1136/bmjopen-2016-014549

Table 2.

CD4/CD8 lymphocyte ratios in vitreous samples

n Mean SD Difference in average value Effect size: d p Value
D-sarcoidosis 61 38.12 124.90 16.99 0.22 >0.9999
S-sarcoidosis 60 21.13 29.94
D-sarcoidosis 61 38.12 124.90 34.86 0.54 <0.0001
Non-sarcoidosis 16 3.26 3.84
D-sarcoidosis 61 38.12 124.90 36.64 0.58 <0.0001
Viral infection 20 1.48 1.07
D-sarcoidosis 61 38.12 124.90 36.25 0.57 <0.0001
Tumour 34 1.87 3.37
D-sarcoidosis 61 38.12 124.90 5.85 0.04 0.0014
Unknown 43 32.27 146.80
S-sarcoidosis 60 21.13 29.94 17.87 1.06 <0.0001
Non-sarcoidosis 16 3.26 3.84
S-sarcoidosis 60 21.13 29.94 19.65 1.27 <0.0001
Viral infection 20 1.48 1.07
S-sarcoidosis 60 21.13 29.94 19.26 1.16 <0.0001
Tumour 34 1.87 3.37
S-sarcoidosis 60 21.13 29.94 11.14 0.13 0.0086
Unknown 43 32.27 146.80
Non-sarcoidosis 16 3.26 3.84 1.78 0.73 >0.9999
Viral infection 20 1.48 1.07
Non-sarcoidosis 16 3.26 3.84 1.39 0.39 >0.9999
Tumour 34 1.87 3.37
Non-sarcoidosis 16 3.26 3.84 29.01 0.39 0.4573
Unknown 43 32.27 146.80
Viral infection 20 1.48 1.07 0.39 0.18 >0.9999
Tumour 34 1.87 3.37
Viral infection 20 1.48 1.07 30.79 0.42 0.0063
Unknown 43 32.27 146.80
Tumour 34 1.87 3.37 30.40 0.40 0.0002
Unknown 43 32.27 146.80